You are here: Home » International » News » Others
Business Standard

Large antibody study offers hope for coronavirus vaccine efforts

Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly, as some earlier reports suggested, scientists have found

Topics
Coronavirus Vaccine | Coronavirus

AP  |  Washington 

Coronavirus, vaccine, covid, drugs, tests, clinical trials

Antibodies that people make to fight the new last for at least four months after diagnosis and do not fade quickly, as some earlier reports suggested, scientists have found.

Tuesday's report, from tests on more than 30,000 people in Iceland, is the most extensive work yet on the immune system's response to the virus and is good news for efforts to develop vaccines.

If a vaccine can spur production of long-lasting antibodies like natural infection does, it gives hope that immunity to this unpredictable and highly contagious virus may not be fleeting, independent experts from Harvard University and the US National Institutes of Health wrote in a commentary published with the study in the New England Journal of Medicine.

One of the big mysteries of the pandemic is whether having had the helps protect against future infection and for how long. Some smaller studies previously suggested that antibodies disappear quickly and that some people with few or no symptoms may not make many at all.

The new study was done by Reykjavik-based deCODE Genetics, a subsidiary of the US biotech company Amgen, with several hospitals, universities and health officials in Iceland.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, September 02 2020. 10:28 IST
RECOMMENDED FOR YOU
.